136 related articles for article (PubMed ID: 31468718)
1. Variability in In Vitro OATP1B1/1B3 Inhibition Data: Impact of Incubation Conditions on Variability and Subsequent Drug Interaction Predictions.
McFeely SJ; Ritchie TK; Ragueneau-Majlessi I
Clin Transl Sci; 2020 Jan; 13(1):47-52. PubMed ID: 31468718
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of Organic Anion-Transporting Polypeptides 1B1 and 1B3: Clinical Relevance and Regulatory Perspective.
McFeely SJ; Ritchie TK; Yu J; Nordmark A; Berglund EG; Levy RH; Ragueneau-Majlessi I
J Clin Pharmacol; 2020 Aug; 60(8):1087-1098. PubMed ID: 32196692
[TBL] [Abstract][Full Text] [Related]
3. Assessment of OATP transporter-mediated drug-drug interaction using physiologically-based pharmacokinetic (PBPK) modeling - a case example.
Chen Y; Zhu R; Ma F; Mao J; Chen EC; Choo EF; Sahasranaman S; Liu L
Biopharm Drug Dispos; 2018 Nov; 39(9):420-430. PubMed ID: 30335192
[TBL] [Abstract][Full Text] [Related]
4. Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.
Farasyn T; Crowe A; Hatley O; Neuhoff S; Alam K; Kanyo J; Lam TT; Ding K; Yue W
J Pharm Sci; 2019 Oct; 108(10):3443-3456. PubMed ID: 31047942
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of Organic Anion-Transporting Polypeptides, OATP1B1/1B3 and 2B1.
Patik I; Székely V; Német O; Szepesi Á; Kucsma N; Várady G; Szakács G; Bakos É; Özvegy-Laczka C
Sci Rep; 2018 Feb; 8(1):2630. PubMed ID: 29422623
[TBL] [Abstract][Full Text] [Related]
6. Calibrating the In Vitro-In Vivo Correlation for OATP-Mediated Drug-Drug Interactions with Rosuvastatin Using Static and PBPK Models.
Sane R; Cheung KWK; Kovács P; Farasyn T; Li R; Bui A; Musib L; Kis E; Plise E; Gáborik Z
Drug Metab Dispos; 2020 Dec; 48(12):1264-1270. PubMed ID: 33037044
[TBL] [Abstract][Full Text] [Related]
7. Identification and Evaluation of Clinical Substrates of Organic Anion Transporting Polypeptides 1B1 and 1B3.
McFeely SJ; Ritchie TK; Yu J; Nordmark A; Levy RH; Ragueneau-Majlessi I
Clin Transl Sci; 2019 Jul; 12(4):379-387. PubMed ID: 30706983
[TBL] [Abstract][Full Text] [Related]
8. Detection of Weak Organic Anion-Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans.
Zhang Y; Holenarsipur VK; Kandoussi H; Zeng J; Mariappan TT; Sinz M; Shen H
Drug Metab Dispos; 2020 Oct; 48(10):841-848. PubMed ID: 32723847
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions.
Izumi S; Nozaki Y; Maeda K; Komori T; Takenaka O; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2015 Feb; 43(2):235-47. PubMed ID: 25414411
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017.
Yu J; Petrie ID; Levy RH; Ragueneau-Majlessi I
Drug Metab Dispos; 2019 Feb; 47(2):135-144. PubMed ID: 30442649
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Determinants of Daprodustat Drug-Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B-CYP2C8 Interplay.
Bi YA; Jordan S; King-Ahmad A; West MA; Varma MVS
Clin Pharmacol Ther; 2024 Jun; 115(6):1336-1345. PubMed ID: 38404228
[TBL] [Abstract][Full Text] [Related]
12. Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition.
Shen H; Christopher L; Lai Y; Gong J; Kandoussi H; Garonzik S; Perera V; Garimella T; Humphreys WG
Drug Metab Dispos; 2018 Aug; 46(8):1075-1082. PubMed ID: 29777022
[TBL] [Abstract][Full Text] [Related]
13. Influence of Rifampin-Mediated Organic Anion-Transporting Polypeptide 1B1/1B3 Inhibition on the Pharmacokinetics of Clazosentan.
Juif PE; Voors-Pette C; Ufer M; Dogterom P; Dingemanse J
Clin Transl Sci; 2019 Sep; 12(5):440-444. PubMed ID: 31004470
[TBL] [Abstract][Full Text] [Related]
14. Role of Hepatic Organic Anion Transporter 2 in the Pharmacokinetics of R- and S-Warfarin: In Vitro Studies and Mechanistic Evaluation.
Bi YA; Lin J; Mathialagan S; Tylaska L; Callegari E; Rodrigues AD; Varma MVS
Mol Pharm; 2018 Mar; 15(3):1284-1295. PubMed ID: 29433307
[TBL] [Abstract][Full Text] [Related]
15. Effect of Rifampin-Mediated OATP1B1 and OATP1B3 Transporter Inhibition on the Pharmacokinetics of the P2Y12 Receptor Antagonist Selatogrel.
Schilling U; Dingemanse J; Voors-Pette C; Romeijn C; Dogterom P; Ufer M
Clin Transl Sci; 2020 Sep; 13(5):886-890. PubMed ID: 32166864
[TBL] [Abstract][Full Text] [Related]
16. Multiple circulating saponins from intravenous ShenMai inhibit OATP1Bs in vitro: potential joint precipitants of drug interactions.
Olaleye OE; Niu W; Du FF; Wang FQ; Xu F; Pintusophon S; Lu JL; Yang JL; Li C
Acta Pharmacol Sin; 2019 Jun; 40(6):833-849. PubMed ID: 30327544
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Organic Anion Transporting Polypeptide 1B1 and 1B3 by Betulinic Acid: Effects of Preincubation and Albumin in the Media.
Oh Y; Jeong YS; Kim MS; Min JS; Ryoo G; Park JE; Jun Y; Song YK; Chun SE; Han S; Bae SK; Chung SJ; Lee W
J Pharm Sci; 2018 Jun; 107(6):1713-1723. PubMed ID: 29462635
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
Takahashi T; Uno Y; Yamazaki H; Kume T
Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
[TBL] [Abstract][Full Text] [Related]
19. Alteration in the Plasma Concentrations of Endogenous Organic Anion-Transporting Polypeptide 1B Biomarkers in Patients with Non-Small Cell Lung Cancer Treated with Paclitaxel.
Mori D; Ishida H; Mizuno T; Kusumoto S; Kondo Y; Izumi S; Nakata G; Nozaki Y; Maeda K; Sasaki Y; Fujita KI; Kusuhara H
Drug Metab Dispos; 2020 May; 48(5):387-394. PubMed ID: 32114508
[TBL] [Abstract][Full Text] [Related]
20. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
